Sentien Biotechnologies Names Dr. Allen R. Nissenson as Chief Medical Officer
LEXINGTON, MA – Sentien Biotechnologies, Inc., a clinical-stage biotechnology company developing novel approaches to cell therapy, today announced the hiring of Allen R. Nissenson, M.D., [...]
